Related references
Note: Only part of the references are listed.Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells
Hanhui Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
K. Ketola et al.
BRITISH JOURNAL OF CANCER (2012)
Rapamycin Resistance Is Linked to Defective Regulation of Skp2
Hana Totary-Jain et al.
CANCER RESEARCH (2012)
Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest
Won Ki Kim et al.
INVESTIGATIONAL NEW DRUGS (2012)
Overexpression of SKP2 Promotes the Radiation Resistance of Esophageal Squamous Cell Carcinoma
Xiao-Chun Wang et al.
RADIATION RESEARCH (2012)
Salinomycin Selectively Targets 'CD133+' Cell Subpopulations and Decreases Malignant Traits in Colorectal Cancer Lines
Tao-Tao Dong et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization
Kwang-Youn Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Salinomycin can effectively kill ALDHhigh stem-like cells on gastric cancer
Qiao Ming Zhi et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
Ju-Hwa Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
Qing-Lian Tang et al.
CANCER LETTERS (2011)
p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
Seth A. Wander et al.
CLINICAL CANCER RESEARCH (2011)
Effects of Salinomycin on Cancer Stem Cell in Human Lung Adenocarcinoma A549 Cells
Yi Wang
MEDICINAL CHEMISTRY (2011)
von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage
J-S Roe et al.
ONCOGENE (2011)
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
Desheng Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China
Hui-Min Xu et al.
Chinese Journal of Cancer (2011)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
Roberta Riccioni et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis
Rinath Jeselsohn et al.
CANCER CELL (2010)
Regulation of Skp2 Levels by the Pim-1 Protein Kinase
Bo Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdh1-mediated Skp2 destruction
Daming Gao et al.
NATURE CELL BIOLOGY (2009)
STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
Maureen M. Sherry et al.
STEM CELLS (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Deathproof: New insights on the role of Skp2 in tumorigenesis
Steven I. Reed
CANCER CELL (2008)
Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APCCdh1 in G1 phase
Genevieve Rodier et al.
EMBO JOURNAL (2008)
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP:: tipping the scales of cancer
David Frescas et al.
NATURE REVIEWS CANCER (2008)
A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells
Mordechai Liscovitch et al.
CANCER LETTERS (2007)
Beyond tumorigenesis: cancer stem cells in metastasis
Feng Li et al.
CELL RESEARCH (2007)
Prognostic impact of Skp2 and p27 in human breast cancer
Frank Traub et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Mechanisms and strategies to overcome multiple drug resistance in cancer
Tomris Ozben
FEBS LETTERS (2006)
Regulation of the cell cycle by SCF-type ubiquitin ligases
KI Nakayama et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Cyclins and cdks in development and cancer: a perspective
A Deshpande et al.
ONCOGENE (2005)
Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase
T Bashir et al.
NATURE (2004)
VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma
HZ Chen et al.
GYNECOLOGIC ONCOLOGY (2004)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Skp2 is oncogenic and overexpressed in human cancers
M Gstaiger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Constitutive activation of Stat 3 oncogene product in human ovarian carcinoma cells
M Huang et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
